Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates. 2015

Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
Department of Laboratory Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. wzjxyfy@163.com.

BACKGROUND A significant trend towards increased fusidic acid (FA) resistance among Staphylococcus aureus with increased duration of use is of concern. The aim of the present study is to investigate the dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates. METHODS The susceptibility of S. aureus isolates to antimicrobial agents was determined by disc-diffusion method. The minimal inhibitory concertrations(MICs) of fusidic acid and vacomycin for fusidic acid-resisitant isolates were determined by ager dillution method. FA resistance determinants were determined by PCR and DNA sequencing. SCCmec typing, spa typing and multi-locus sequence typing were used for the determination of molecular characteristics for S. aureus isolates. RESULTS A total of 392 non-duplicate S. aureus isolates including 181 methicillin-resistant S. aureus (MRSA) isolates, which were isolated from the clinical specimens of patients at a Chinese tertiary hospital from January, 2012 to September, 2013, were collected for investigating FA resistance. Among 392 S. aureus clinical isolates tested, 56 (14.3%) with FA MIC values ranging from 2 μg/ml to ≥128 μg/ml were resistant to FA. The proportions of FA resistance among MRSA and MSSA isolates were 27.1% (49/181) and 3.3% (7/211). There was a trend of rapidly increased FA resistance among S. aureus and MRSA isolates from 5.2% and 8.9% in 2012 to 24.9% and 45.1% in 2013. Acquired FA resistance gene, fusB, was present in 73.2% (41/56) of FA-resistant S. aureus isolates. fusC and fusA mutation were not found in any of tested isolates. A total of 9 sequence types (STs) and 12 spa types were identified among the 56 FA-resistant S. aureus isolates. ST5 accounting for 66.1% (37/56) was the most prevalent ST. The majority (92.9%, 52/56) of the isolates tested belonged to clonal complex 5(CC5). t2460 was the most prevalent spa type, accounting for 67.9% (38/56) . ST5-MRSA- II-t2460 was predominant clone, accounting for 75.5% (37/49) of FA-resistant MRSA isolates and 66.1% (37/56) of FA-resistant S. aureus isolates. Five of 7 FA-resistant MSSA isolates belonged to ST630-MSSA. CONCLUSIONS Increased FA resistance among S. aureus isolates was found in China. fusB was predominant FA resistance determinant. The spread of CC5 clone, especially novel ST5-MRSA- II-t2460 clone with high-level resistance to FA, was responsible for the increase of FA resistance.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D005672 Fusidic Acid An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis. Fucithalmic,Fusidate Sodium,Fusidic Acid, Sodium Salt,Fusidin,Silver Fusidate,Sodium Fusidate,Stanicide,Acid, Fusidic,Fusidate, Silver,Fusidate, Sodium,Sodium, Fusidate
D005798 Genes, Bacterial The functional hereditary units of BACTERIA. Bacterial Gene,Bacterial Genes,Gene, Bacterial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
August 2017, Oncotarget,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
December 2010, Antimicrobial agents and chemotherapy,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
March 2002, Lancet (London, England),
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
January 2022, Infection and drug resistance,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
May 2009, Antimicrobial agents and chemotherapy,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
May 2011, BMC microbiology,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
April 2003, The Journal of antimicrobial chemotherapy,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
January 2021, Frontiers in medicine,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
January 2004, Archives of disease in childhood,
Fangyou Yu, and Yunling Liu, and Chaohui Lu, and Jinnan Lv, and Xiuqin Qi, and Yu Ding, and Dan Li, and Xiaoying Huang, and Longhua Hu, and Liangxing Wang
March 2004, International journal of dermatology,
Copied contents to your clipboard!